Analysis Of Molecular Responses and Chromosomal Aberrations In Patients With Polycythemia Vera Treated With Peg-Proline-Interferon Alpha-2b (AOP2014/P1101) In The Peginvera Study
Nicole C.C. Them(Austrian Academy of Sciences), Róbert Královics(Medical University of Vienna), Richard Greil(Paracelsus Medical University), Ernst Schloegl(Hanusch Hospital), Heinz Gisslinger(Medical University of Vienna), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Christoph Klade(Intercell (Austria)), Josef Thaler(Thrombolysis in Myocardial Infarction Study Group), Tiina Berg(Austrian Academy of Sciences), Klaudia Bagienski(Austrian Academy of Sciences), Guenther Gastl(Innsbruck Medical University), Oleh Zahriychuk(AOP Orphan (Austria))
Cited by 3
Related Papers
A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders
|New England Journal of Medicine|2005|3.5k
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450